Canada markets closed

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.3400-0.0150 (-4.23%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 48.78M
Enterprise Value 42.68M
Trailing P/E 13.29
Forward P/E 17.76
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.19
Price/Book (mrq)1.79
Enterprise Value/Revenue 1.90
Enterprise Value/EBITDA 7.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.23
52-Week Change 3-7.69%
S&P500 52-Week Change 321.23%
52 Week High 30.4700
52 Week Low 30.2300
50-Day Moving Average 30.3840
200-Day Moving Average 30.3422

Share Statistics

Avg Vol (3 month) 371.56k
Avg Vol (10 day) 336.13k
Shares Outstanding 5137.42M
Implied Shares Outstanding 6137.42M
Float 8115.6M
% Held by Insiders 114.35%
% Held by Institutions 10.42%
Shares Short (Mar 28, 2024) 41.2k
Short Ratio (Mar 28, 2024) 40.03
Short % of Float (Mar 28, 2024) 4N/A
Short % of Shares Outstanding (Mar 28, 2024) 40.00%
Shares Short (prior month Feb 29, 2024) 4136

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 02, 1999
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 16.57%
Operating Margin (ttm)30.56%

Management Effectiveness

Return on Assets (ttm)1.87%
Return on Equity (ttm)14.66%

Income Statement

Revenue (ttm)22.42M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)236.00%
Gross Profit (ttm)N/A
EBITDA 1.94M
Net Income Avi to Common (ttm)3.72M
Diluted EPS (ttm)0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.78M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)6.68M
Total Debt/Equity (mrq)24.53%
Current Ratio (mrq)8.53
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)958.26k
Levered Free Cash Flow (ttm)-794.45k